balance equationinconsistent2019-12-31
Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.
Revenue
$0
Fiscal year ended 2025-12-31Operating income
-$13.54M
Fiscal year ended 2025-12-31Free cash flow
-$14.17M
Fiscal year ended 2025-12-31Vivani Medical, Inc. (VANI) reported revenue of $0 and net income of -$13.16M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Vivani Medical, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Electromedical & Electrotherapeutic Apparatus.
Income
| Metric | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2021-06-30 | 2020-06-30 | 2019-12-31 | 2019-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | Unavailable | $0 | $0 | Unavailable | $472.00K |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $0 | $0 | Unavailable | $364.00K |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $0 | $0 | Unavailable | $108.00K |
| Operating income | -$13.54M | -$7.46M | -$6.56M | -$6.46M | -$6.31M | -$5.68M | -$2.30M | -$3.12M | Unavailable | -$7.62M |
| Net income | -$13.16M | -$7.14M | -$6.30M | -$6.05M | -$6.04M | -$5.36M | -$2.68M | -$3.10M | Unavailable | -$7.58M |
| Research & development | $9.15M | $4.76M | $4.22M | $4.30M | $4.20M | $3.51M | $695.00K | $323.00K | Unavailable | $3.38M |
| Weighted-average diluted shares | Unavailable | shares 59.24M | shares 59.24M | Unavailable | shares 55.25M | shares 55.02M | Unavailable | Unavailable | Unavailable | Unavailable |
| Pretax income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Income tax expense | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Diluted EPS | Unavailable | $-0.12 | $-0.11 | Unavailable | $-0.11 | $-0.10 | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $3.49M |
| General & administrative | $4.39M | $2.70M | $2.34M | $2.16M | $2.11M | $2.17M | $1.34M | $1.52M | Unavailable | $2.18M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $1.31M |
Balance
| Metric | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2021-06-30 | 2020-06-30 | 2019-12-31 | 2019-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $16.23M | $6.79M | $13.01M | $18.35M | $19.65M | $24.92M | $73.84M | $3.50M | Unavailable | $18.46M |
| Total assets | $39.39M | $28.90M | $35.45M | $41.56M | $42.90M | $48.22M | $75.92M | $4.80M | Unavailable | $23.90M |
| Current assets | $17.90M | $8.72M | $14.85M | $20.44M | $21.40M | $26.34M | $75.44M | $4.58M | Unavailable | $20.36M |
| Total liabilities | $23.66M | $24.00M | $23.83M | $23.95M | $24.56M | $24.40M | $3.81M | $2.72M | Unavailable | $9.61M |
| Current liabilities | $6.60M | $6.72M | $6.20M | $5.99M | $6.27M | $5.78M | $3.66M | $2.72M | Unavailable | $7.18M |
| Total equity incl. NCI | $15.73M | $4.91M | $11.62M | $17.61M | $18.33M | $23.82M | $1.40M | $2.08M | Unavailable | $14.29M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $1.26M |
| Accounts receivable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $264.00K |
| Goodwill | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | $1.03M | $1.76M | $1.00M | $817.00K | $815.00K | $645.00K | $670.00K | $517.00K | Unavailable | $1.13M |
Cash flow
| Metric | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2021-06-30 | 2020-06-30 | 2019-12-31 | 2019-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$13.07M | -$6.09M | -$5.16M | -$5.81M | -$5.66M | Unavailable | Unavailable | Unavailable | Unavailable | -$6.46M |
| Capital expenditures | $1.10M | $71.00K | $5.00K | $296.00K | $41.00K | Unavailable | Unavailable | Unavailable | Unavailable | $230.00K |
| Investing cash flow | -$1.10M | -$71.00K | -$5.00K | -$296.00K | -$41.00K | Unavailable | Unavailable | Unavailable | Unavailable | -$230.00K |
| Financing cash flow | $23.54M | -$95.00K | -$170.00K | $4.83M | $427.00K | Unavailable | Unavailable | Unavailable | Unavailable | $0 |
| Net change in cash | $9.44M | -$6.21M | -$5.34M | -$1.29M | -$5.27M | Unavailable | Unavailable | Unavailable | Unavailable | -$6.70M |
| Stock-based compensation | $743.00K | $391.00K | $350.00K | $402.00K | $472.00K | Unavailable | Unavailable | Unavailable | Unavailable | $686.00K |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $220.00K | $100.00K | $102.00K | $89.00K | $107.00K | $103.00K | Unavailable | Unavailable | Unavailable | $97.00K |
Derived
| Metric | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2021-06-30 | 2020-06-30 | 2019-12-31 | 2019-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | -$14.17M | -$6.16M | -$5.17M | -$6.11M | -$5.70M | Unavailable | Unavailable | Unavailable | Unavailable | -$6.69M |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 22.9% |
| Operating margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | -1614.2% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | -1416.9% |
| SBC / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current ratio | 2.71x | 1.30x | 2.40x | 3.41x | 3.41x | 4.55x | 20.61x | 1.68x | Unavailable | 2.83x |
| Revenue YoY growth | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | -100.0% | Unavailable | -79.0% |
| Net margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | -1606.8% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open VANI in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-26View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-13View SEC filing
Reconciliation checks needing review
5 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
gross profit bridgeinconsistent2019-12-31
Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.
balance equationinconsistent2018-12-31
Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.
gross profit bridgeinconsistent2018-12-31
Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.
balance equationreview2021-06-30
Difference 70706000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.